SPR PNS for Chronic Shoulder Pain
Launched by INTERNATIONAL SPINE, PAIN AND PERFORMANCE CENTER · Dec 5, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called SPR PNS for Chronic Shoulder Pain, is looking into how well a device called the SPRINT Peripheral Nerve Stimulation (PNS) System works for treating long-lasting shoulder pain. This pain can come from issues like arthritis or injuries to the shoulder. The SPRINT PNS system uses mild electrical stimulation to help relieve pain and involves placing small wires under the skin of your shoulder, which connect to a wearable device that provides the stimulation. The goal of the study is to gather information about how effective this treatment is for patients experiencing chronic shoulder pain.
To participate in this trial, you need to be at least 21 years old and have been diagnosed with degenerative changes in your shoulder. You should also be scheduled for the SPRINT PNS procedure and have a pain score higher than 5 on a specific questionnaire. Participants in the study can expect to follow certain guidelines and share their experiences with the treatment. It's important to note that individuals with certain conditions, such as recent shoulder surgery or specific nerve issues, may not be eligible. Overall, this trial aims to provide valuable insights into a new option for managing chronic shoulder pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 21 years old
- • Diagnosed with degenerative changes within the shoulder complex
- • Scheduled for a commercial SPRINT PNS procedure
- • Shoulder pain score at baseline \>5 as demonstrated by PROMIS 29
- • Able to understand and willing to take part in study and comply with all study requirements
- Exclusion Criteria:
- • No shoulder pain at rest
- • Pain exclusively in the anterior aspect of the shoulder
- • Confounding conditions such as cervical radiculopathy, inflammatory arthritis, complete rotator cuff tear, or ipsilateral shoulder surgery in the past one year
- • Daily opioid use \>90 m morphine equivalent at any point in the past month
- • Opioids for any condition other than shoulder pain
- • Deep brain stimulation (DBS) system, implanted active cardiac implant (e.g. pacemaker or defibrillator), or any other implantable neuro-stimulator whose stimulus current pathway may overlap with the SPRINT system.
- • Any other condition that may interfere with the ability to participate in a clinical trial (e.g. anatomy that may interfere with lead placement, nerve damage, compromised immune system, uncontrolled DM) as determined by the Investigator
- • Vulnerable populations (e.g., prisoners, minors, students, employees)
- • Workers Compensation
- • Pregnant
Trial Officials
Mehul Desai, MD, MPH
Principal Investigator
International Spine Pain & Performance Center
About International Spine, Pain And Performance Center
The International Spine, Pain and Performance Center is a leading clinical trial sponsor dedicated to advancing the understanding and treatment of spinal disorders and pain management. With a focus on innovative research and evidence-based practices, the center collaborates with healthcare professionals and institutions to conduct rigorous clinical trials that aim to improve patient outcomes and enhance the quality of life for individuals suffering from chronic pain and related conditions. Committed to excellence in clinical research, the center prioritizes patient safety and ethical standards while contributing to the development of groundbreaking therapies and interventions in the field of spine health and performance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Arlington, Virginia, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials